Imricor Medical Systems Inc (imr) Logo

Imricor Medical Systems Inc (IMR)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

IMR ASX Chart

Snapshot

Imricor Medical Systems, Inc. (IMR) is a developer of innovative MRI-compatible medical devices which can be used to carry out real-time iCMR cardiac ablation procedures. Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac ablation procedures.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -29.29%
vs ASX 200 (1yr) -26.30%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 822 of 2,358
Sector Rank 62 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OIL / M7T / GSS
EPS -$0.168
DPS $0.00
Book Value Per Share -$0.032

Broker Consensus

IMR is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Burnsville Minnesot USA 55337
Website www.imricor.com
Registry Computershare
Auditor BDO
Date Listed 30 Aug 2019

Upcoming Calendar (Forecasted)

Date Event
27/02/2025 Report (Prelim)
04/03/2025 Report (Prelim)
08/04/2025 Report (Annual)
27/08/2025 Report (Interim)

Former Company Names

  • Imricor Medical Systems Inc has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

IMR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
06/06/24 Steve Wedan Issued 2,113,342 $0.45 $951,003 Issue of options
22/05/24 Steve Wedan Buy +100,000 $0.45 $45,000 Off-market trade
21/05/24 Anita Messal Issued 100,834 $0.445 $44,871 Issue of securities
21/05/24 Mark Tibbles Issued 107,556 $0.445 $47,862 Issue of securities
21/05/24 Peter McGregor Issued 107,556 $0.445 $47,862 Issue of securities
07/05/24 Peter McGregor Buy +100,000 $0.484 $48,368 On-market trade
28/02/24 Peter McGregor Issued 78,271 $0.45 $35,221 Rights issue
02/06/23 Steve Wedan Expiry 173,756 $0.32 $55,601 Options expired
02/06/23 Steve Wedan Issued 1,426,949 $0.32 $456,623 Issue of options
19/05/23 Peter McGregor Issued 179,775 $0.265 $47,640 Issue of securities
19/05/23 Anita Messal Issued 168,539 $0.265 $44,662 Issue of securities
19/05/23 Mark Tibbles Issued 179,775 $0.265 $47,640 Issue of securities
16/03/23 Mark Tibbles Buy +505,000 $0.34 $171,700 On-market trade
10/03/23 Mark Tibbles Buy +574,451 $0.34 $195,313 On-market trade
02/03/23 Steve Wedan Buy +97,540 $0.32 $31,212 On-market trade
14/11/22 Steve Wedan Buy +23,000 $0.371 $8,540 On-market trade
10/11/22 Steve Wedan Buy +263,313 $0.29 $76,300 On-market trade
17/06/22 Peter McGregor Issued 107,253 $0.373 $40,005 Employee Share Ownership Plan
17/06/22 Mark Tibbles Issued 107,253 $0.373 $40,005 Employee Share Ownership Plan
17/06/22 Anita Messal Issued 83,791 $0.373 $31,254 Employee Share Ownership Plan
17/06/22 Steve Wedan Issued 1,098,627 $0.115 $126,342 Issue of options
14/06/22 Peter McGregor Buy +100,000 $0.171 $17,110 On-market trade
07/06/22 Peter McGregor Buy +200,000 $0.243 $48,575 On-market trade
24/03/22 Mark Tibbles Buy +175,000 $0.29 $50,750 Off-market trade
24/03/22 Steve Wedan Buy +175,000 $0.29 $50,750 Off-market trade
07/05/21 Steve Wedan Issued 304,254 $2.00 $608,508 Issue of options
07/05/21 Mark Tibbles Issued 40,896 $2.00 $81,792 Issue of options
07/05/21 Peter McGregor Issued 40,896 $2.00 $81,792 Issue of options
07/05/21 Anita Messal Issued 38,340 $2.00 $76,680 Issue of options
14/05/20 Steve Wedan Issued 579,187 $1.34 $776,110 Issue of options
14/05/20 Mark Tibbles Issued 71,010 $1.34 $95,153 Issue of options
14/05/20 Doris Engibous Issued 66,571 $1.34 $89,205 Issue of options
14/05/20 Peter McGregor Issued 71,010 $1.34 $95,153 Issue of options
31/12/19 Steve Wedan Transfer 2,518,219 $1.20 $3,009,272 Off-market transfer
31/12/19 Steve Wedan Transfer 2,518,219 $1.20 $3,009,272 Off-market transfer
31/12/19 Mark Tibbles Issued 2,897 $1.20 $3,462 Conversion of convertible notes
31/12/19 Steve Wedan Issued 501 $1.20 $599 Conversion of convertible notes
24/12/19 Mark Tibbles Buy +30,000 $0.341 $10,230 Exercise of options
24/12/19 Mark Tibbles Exercise 30,000 $0.341 $10,230 Exercise of options
Show All

Director Interests

The current holdings of IMR directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Jeffrey Leighton 31/07/2024 N/A 245,746 N/A N/A
Steve Wedan 06/06/2024 0 5,083,586 6,783,667 N/A
Anita Messal 21/05/2024 353,164 665,479 38,340 N/A
Mark Tibbles 21/05/2024 6,230,913 N/A 526,806 N/A
Peter McGregor 21/05/2024 252,330 873,035 246,906 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Mar 25, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited <Domestic Hin A/C> 21,527,041 11.44%
HSBC Custody Nominees (Australia) Limited 17,838,946 9.48%
Warren G Herreid Ii 9,486,098 5.04%
Bnp Paribas Noms (Nz) Ltd 9,002,900 4.78%
Hsbc Custody Nominees (Australia) Limited A/C 2 8,544,746 4.54%
Siemens Medical Solutions Usa Inc 8,384,150 4.46%
Hr Global Investments Llc 6,879,579 3.66%
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 4,649,106 2.47%
UBS Nominees Pty Ltd 3,333,334 1.77%
Kahr Foundation 2,950,988 1.57%
Steven R Wedan 2,693,720 1.43%
Maclay Group Pty Ltd <Maclay Longhurst Family A/C> 1,761,113 0.94%
Bauer Private Equity Fund Vi Llc 1,696,555 0.90%
Matthew James Banfield 1,461,868 0.78%
Steven R Wedan & Cherri J Wedan Jt Ten 1,427,373 0.76%
Merrill Lynch (Australia) Nominees Pty Limited 1,358,832 0.72%
Ronald D Berger 1,300,000 0.69%
Pacific Premier Trust Cust Fbo Jeffrey J Quinn Ira 1,288,462 0.68%
Stojanov Investment Pty Ltd <Stojanov Family A/C> 1,236,363 0.66%
Bradica Nominees Pty Ltd <L & J Bradica S/F A/C> 1,185,750 0.63%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 214 280 101 405 240 1,240

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
HR Global Investments LLC 25/03/2024 11,204,996 5.95
Warren G Herreid II and KAHR Foundation 25/03/2024 12,437,086 6.61
Saville Capital 25/03/2024 12,850,001 6.83

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
19-03-24 Siemens Medical Solutions USA Inc 8,384,150 5.42 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.53 28 June
2023 $0.33 30 June
2022 $0.245 30 June
2021 $2.00 30 June
2020 $1.49 30 June
IMR Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.